Behrang Mahjani, PhD
img_Behrang Mahjani
ASSISTANT PROFESSOR | Psychiatry
ASSISTANT PROFESSOR | Artificial Intelligence and Human Health
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics
Autism, Gene Discovery, Genomics
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
Genetic risk architecture of neuropsychiatric disorders
The goal of our research group is to better understand the developmental mechanisms and trajectories of childhood neuropsychiatric disorders, from the prenatal period through adolescence. We are keen to leverage large-scale data and statistical and computational methods to facilitate precision psychiatric approaches.
Perinatal Mental Health
We study the interplay of genetic and environmental factors influencing mental health disorders during pregnancy and their impact on child development. Our group strives to integrate cutting-edge computational genomics, epidemiological studies, and statistical genetics approaches to achieve this goal.

BSc - Applied Mathematics, KNT University of Technology

MSc - Complex Adaptive Systems, Chalmers University of Technology

MSc - Mathematical Statistics, Chalmers University of Technology

PhD - Statistical and Scientific Computing, Uppsala University

Postdoctoral Fellowship - Epidemiology and Biostat, Karolinska Institutet

Postdoctoral Fellowship - Biological Psychiatry, Icahn School of Medicine at Mount Sinai

2023

Risk architecture of postpartum psychosis

National Institute of Mental Health

2020

Prenatal Maternal Depression And Anxiety, And Risk Of Neurodevelopmental Disorders In Children

Brain & Behavior Research Foundation

Publications

Selected Publications

Contribution of autosomal rare and de novo variants to sex differences in autism. Mahmoud Koko, F. Kyle Satterstrom, Branko Aleksic, Mykyta Artomov, Mafalda Barbosa, Elisa Benetti, Catalina Betancur, Monica Biscaldi-Schafer, Anders D. Børglum, Harrison Brand, Alfredo Brusco, Joseph D. Buxbaum, Gabriele Campos, Simona Cardaropoli, Diana Carli, Angel Carracedo, Marcus C.Y. Chan, Andreas G. Chiocchetti, Brian H.Y. Chung, Brett Collins, Ryan L. Collins, Edwin H. Cook, Hilary Coon, Claudia I.S. Costa, Michael L. Cuccaro, David J. Cutler, Mark J. Daly, Silvia De Rubeis, Bernie Devlin, Ryan N. Doan, Enrico Domenici, Shan Dong, Chiara Fallerini, Montserrat Fernández-Prieto, Giovanni Battista Ferrero, Christine M. Freitag, Jack M. Fu, J. Jay Gargus, Sherif Gerges, Elisa Giorgio, Ana Cristina Girardi, Stephen Guter, Emily Hansen-Kiss, Gail E. Herman, Irva Hertz-Picciotto, David M. Hougaard, Alexander Kolevzon, Behrang Mahjani, Abraham Reichenberg, Sven Sandin. American Journal of Human Genetics

A Family Peer Advocate Model to Address Disparities in Access to Care for Minority Autistic Children with Co-Occurring Attention-Deficit/Hyperactivity Disorder. Pilar Trelles, Behrang Mahjani, Emma Wilkinson, Nicholas Buonagura, Lauren Donnelly, Jennifer Foss Feig, Danielle Halpern, Mary McKay, Paige Siper, Joseph D. Buxbaum, Alexander Kolevzon. Journal of Developmental and Physical Disabilities

Interactions of perinatal depression versus anxiety and infants' early temperament trajectories. Ferdinand Sörensen, Mary C. Kimmel, Vera Brenner, Ingeborg Krägeloh-Mann, Alkistis Skalkidou, Behrang Mahjani, Emma Fransson. Child Development

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Mahjani has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.